Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Johnson and Johnson
AstraZeneca
McKinsey
Merck

Last Updated: September 26, 2022

Woodward Specl Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for WOODWARD SPECL, and what generic and branded alternatives to WOODWARD SPECL drugs are available?

WOODWARD SPECL has four approved drugs.



Summary for Woodward Specl
US Patents:0
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for Woodward Specl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Woodward Specl THIOGUANINE thioguanine TABLET;ORAL 012429-001 Approved Prior to Jan 1, 1982 RX Yes Yes See Plans and Pricing See Plans and Pricing
Woodward Specl MYLERAN busulfan TABLET;ORAL 009386-001 Approved Prior to Jan 1, 1982 RX Yes Yes See Plans and Pricing See Plans and Pricing
Woodward Specl DECA-DURABOLIN nandrolone decanoate INJECTABLE;INJECTION 013132-001 Jun 12, 1986 DISCN No No See Plans and Pricing See Plans and Pricing
Woodward Specl DECA-DURABOLIN nandrolone decanoate INJECTABLE;INJECTION 013132-003 Jun 12, 1986 DISCN Yes No See Plans and Pricing See Plans and Pricing
Woodward Specl DECA-DURABOLIN nandrolone decanoate INJECTABLE;INJECTION 013132-002 Jun 12, 1986 DISCN No No See Plans and Pricing See Plans and Pricing
Woodward Specl LEUKERAN chlorambucil TABLET;ORAL 010669-002 Approved Prior to Jan 1, 1982 RX Yes Yes See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Baxter
Moodys
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.